On Implementation of ICH S1 Guideline Based on a Retrospective Analysis of Approved New Drugs by U.S. FDA in the Past Five Years

Zhang Sucai, Yao Dalin, Sun Yunxia, Sun Tao

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (11) : 1295-1309.

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (11) : 1295-1309. DOI: 10.16153/j.1002-7777.2019.11.013
Foreign Pharmacy

On Implementation of ICH S1 Guideline Based on a Retrospective Analysis of Approved New Drugs by U.S. FDA in the Past Five Years

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 33(11): 1295-1309 https://doi.org/10.16153/j.1002-7777.2019.11.013

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/